Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 23‏‎ (1 revision)
  2. DRL quantity‏‎ (1 revision)
  3. Ras‏‎ (1 revision)
  4. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  5. Designated area‏‎ (1 revision)
  6. Reference phantom‏‎ (1 revision)
  7. ICRP Publication 44‏‎ (1 revision)
  8. Distribution coefficient‏‎ (1 revision)
  9. ICRP Publication 90‏‎ (1 revision)
  10. ICRP Publication 59‏‎ (1 revision)
  11. ICRP Publication 73‏‎ (1 revision)
  12. Size-specific dose estimate‏‎ (1 revision)
  13. ICRP Publication 88‏‎ (1 revision)
  14. Epigenetic effects‏‎ (1 revision)
  15. Specific absorbed fraction‏‎ (1 revision)
  16. 1928 Recommendations‏‎ (1 revision)
  17. Surface contamination‏‎ (1 revision)
  18. Additive risk projection model‏‎ (1 revision)
  19. Translocation‏‎ (1 revision)
  20. Multistage carcinogenesis model‏‎ (1 revision)
  21. ICRP Publication 106‏‎ (1 revision)
  22. Phantom‏‎ (1 revision)
  23. ICRP Publication 12‏‎ (1 revision)
  24. ICRP Publication 134‏‎ (1 revision)
  25. Cobblestone area forming cell assay‏‎ (1 revision)
  26. ICRP Publication 149‏‎ (1 revision)
  27. ICRP Publication 24‏‎ (1 revision)
  28. Rb‏‎ (1 revision)
  29. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  30. Detector quantum efficiency‏‎ (1 revision)
  31. Reference value‏‎ (1 revision)
  32. ICRP Publication 45‏‎ (1 revision)
  33. ICRP Publication 91‏‎ (1 revision)
  34. ICRP Publication 6‏‎ (1 revision)
  35. ICRP Publication 74‏‎ (1 revision)
  36. Slice‏‎ (1 revision)
  37. ICRP Publication 89‏‎ (1 revision)
  38. Exogenous excretion‏‎ (1 revision)
  39. 1931 Recommendations‏‎ (1 revision)
  40. Threshold level‏‎ (1 revision)
  41. Adenoma‏‎ (1 revision)
  42. Organ at risk‏‎ (1 revision)
  43. ICRP Publication 107‏‎ (1 revision)
  44. ICRP Publication 120‏‎ (1 revision)
  45. Carers and comforters‏‎ (1 revision)
  46. Principles of protection‏‎ (1 revision)
  47. ICRP Publication 135‏‎ (1 revision)
  48. Radiation-induced second cancer‏‎ (1 revision)
  49. ICRP Publication 15‏‎ (1 revision)
  50. ICRP Publication 150‏‎ (1 revision)
  51. Radiological attack‏‎ (1 revision)
  52. ICRP Publication 25‏‎ (1 revision)
  53. Reactive oxygen species‏‎ (1 revision)
  54. ICRP Publication 31‏‎ (1 revision)
  55. Deterministic effect‏‎ (1 revision)
  56. Reference worker‏‎ (1 revision)
  57. ICRP Publication 46‏‎ (1 revision)
  58. ICRP Publication 92‏‎ (1 revision)
  59. ICRP Publication 60‏‎ (1 revision)
  60. Dose modifying factor‏‎ (1 revision)
  61. ICRP Publication 75‏‎ (1 revision)
  62. Informed consent‏‎ (1 revision)
  63. ICRP Publication 9‏‎ (1 revision)
  64. Spongiosa‏‎ (1 revision)
  65. 1934 Recommendations‏‎ (1 revision)
  66. Access control‏‎ (1 revision)
  67. Marrow cellularity‏‎ (1 revision)
  68. General Information: Radon‏‎ (1 revision - redirect page)
  69. Multitarget equation‏‎ (1 revision)
  70. ICRP Publication 108‏‎ (1 revision)
  71. Brachytherapy‏‎ (1 revision)
  72. Pilomatricoma‏‎ (1 revision)
  73. ICRP Publication 121‏‎ (1 revision)
  74. Case–control study‏‎ (1 revision)
  75. ICRP Publication 136‏‎ (1 revision)
  76. Collective dose‏‎ (1 revision)
  77. Radiation-induced secondary malignancy‏‎ (1 revision)
  78. ICRP Publication 151‏‎ (1 revision)
  79. Radiological controlled area‏‎ (1 revision)
  80. ICRP Publication 26‏‎ (1 revision)
  81. DS86‏‎ (1 revision)
  82. ICRP Publication 32‏‎ (1 revision)
  83. Referrer‏‎ (1 revision)
  84. ICRP Publication 47‏‎ (1 revision)
  85. ICRP Publication 93‏‎ (1 revision)
  86. ICRP Publication 61‏‎ (1 revision)
  87. ICRU 4-element tissue‏‎ (1 revision)
  88. ICRP Publication 76‏‎ (1 revision)
  89. Equilibrium equivalent concentration‏‎ (1 revision)
  90. Expanded radiation field‏‎ (1 revision)
  91. 1937 Recommendations‏‎ (1 revision)
  92. System of radiological protection‏‎ (1 revision)
  93. Time-resolved computed tomography‏‎ (1 revision)
  94. Adventitious source‏‎ (1 revision)
  95. Mutation component‏‎ (1 revision)
  96. Annual intake‏‎ (1 revision)
  97. Waste management‏‎ (1 revision)
  98. Normal tissue complication probability‏‎ (1 revision)
  99. ICRP Publication 109‏‎ (1 revision)
  100. ICRP Publication 122‏‎ (1 revision)
  101. ICRP Publication 137‏‎ (1 revision)
  102. ICRP Publication 152‏‎ (1 revision)
  103. ICRP Publication 27‏‎ (1 revision)
  104. ICRP Publication 33‏‎ (1 revision)
  105. Detriment-adjusted risk‏‎ (1 revision)
  106. Region‏‎ (1 revision)
  107. ICRP Publication 48‏‎ (1 revision)
  108. Dose-response function‏‎ (1 revision)
  109. ICRP Publication 94‏‎ (1 revision)
  110. ICRP Publication 62‏‎ (1 revision)
  111. ICRU sphere‏‎ (1 revision)
  112. ICRP Publication 77‏‎ (1 revision)
  113. Equilibrium factor‏‎ (1 revision)
  114. 1950 Recommendations‏‎ (1 revision)
  115. Treatment preparation in radiotherapy‏‎ (1 revision)
  116. Notification value‏‎ (1 revision)
  117. Backscatter factor‏‎ (1 revision)
  118. Other (systemic) tissues‏‎ (1 revision)
  119. ICRP Publication 10A‏‎ (1 revision)
  120. ICRP Publication 123‏‎ (1 revision)
  121. Charged-particle equilibrium‏‎ (1 revision)
  122. ICRP Publication 138‏‎ (1 revision)
  123. Collimation‏‎ (1 revision)
  124. ICRP Publication 153‏‎ (1 revision)
  125. ICRP Publication 28‏‎ (1 revision)
  126. ICRP Publication 34‏‎ (1 revision)
  127. Regional diagnostic reference levels‏‎ (1 revision)
  128. ICRP Publication 49‏‎ (1 revision)
  129. ICRP Publication 95‏‎ (1 revision)
  130. ICRP Publication 63‏‎ (1 revision)
  131. Sealed source‏‎ (1 revision)
  132. ICRP Publication 78‏‎ (1 revision)
  133. Elemental dose‏‎ (1 revision)
  134. Solar flare‏‎ (1 revision)
  135. Exposed individuals‏‎ (1 revision)
  136. 1954 Recommendations‏‎ (1 revision)
  137. Linear dose response‏‎ (1 revision)
  138. Mean glandular dose‏‎ (1 revision)
  139. Trophic level‏‎ (1 revision)
  140. Apoptosis‏‎ (1 revision)
  141. Nuclear medicine‏‎ (1 revision)
  142. ICRP Publication 11‏‎ (1 revision)
  143. Pooled analysis‏‎ (1 revision)
  144. ICRP Publication 124‏‎ (1 revision)
  145. ICRP Publication 139‏‎ (1 revision)
  146. Radiation risk‏‎ (1 revision)
  147. ICRP Publication 154‏‎ (1 revision)
  148. Cosmic radiation‏‎ (1 revision)
  149. ICRP Publication 29‏‎ (1 revision)
  150. ICRP Publication 35‏‎ (1 revision)
  151. Registry‏‎ (1 revision)
  152. ICRP Publication 5‏‎ (1 revision)
  153. Dose-threshold hypothesis‏‎ (1 revision)
  154. ICRP Publication 96‏‎ (1 revision)
  155. ICRP Publication 64‏‎ (1 revision)
  156. Secondary radiation‏‎ (1 revision)
  157. ICRP Publication 79‏‎ (1 revision)
  158. Intake‏‎ (1 revision)
  159. Standard-size adult‏‎ (1 revision)
  160. 1956 Recommendations‏‎ (1 revision)
  161. Activation‏‎ (1 revision)
  162. Tissue reaction‏‎ (1 revision)
  163. Measured quantity‏‎ (1 revision)
  164. Tumour suppressor gene‏‎ (1 revision)
  165. National DRL‏‎ (1 revision)
  166. ICRP Publication 1‏‎ (1 revision)
  167. Baseline disease rates‏‎ (1 revision)
  168. Oxygen enhancement ratio‏‎ (1 revision)
  169. ICRP Publication 110‏‎ (1 revision)
  170. Breakpoint cluster region/abelson‏‎ (1 revision)
  171. Population risk‏‎ (1 revision)
  172. ICRP Publication 125‏‎ (1 revision)
  173. ICRP Publication 14‏‎ (1 revision)
  174. Commissioning‏‎ (1 revision)
  175. ICRP Publication 155‏‎ (1 revision)
  176. ICRP Publication 3‏‎ (1 revision)
  177. Redox‏‎ (1 revision)
  178. ICRP Publication 36‏‎ (1 revision)
  179. Dicentric chromosome‏‎ (1 revision)
  180. ICRP Publication 50‏‎ (1 revision)
  181. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  182. ICRP Publication 97‏‎ (1 revision)
  183. ICRP Publication 65‏‎ (1 revision)
  184. Secretory cells‏‎ (1 revision)
  185. ICRP Publication 8‏‎ (1 revision)
  186. Intensity-modulated radiotherapy‏‎ (1 revision)
  187. Stem cell‏‎ (1 revision)
  188. Kerma approximation‏‎ (1 revision)
  189. 1959 Decisions‏‎ (1 revision)
  190. National radon survey‏‎ (1 revision)
  191. Hereditary effect‏‎ (1 revision)
  192. ICRP Publication 10‏‎ (1 revision)
  193. ICRP Publication 111‏‎ (1 revision)
  194. Potential alpha energy concentration‏‎ (1 revision)
  195. ICRP Publication 126‏‎ (1 revision)
  196. ICRP Publication 140‏‎ (1 revision)
  197. ICRP Publication 16‏‎ (1 revision)
  198. ICRP Publication 30‏‎ (1 revision)
  199. Dental and maxillofacial imaging‏‎ (1 revision)
  200. ICRP Publication 37‏‎ (1 revision)
  201. Relative biological effectiveness‏‎ (1 revision)
  202. ICRP Publication 51‏‎ (1 revision)
  203. ICRP Publication 98‏‎ (1 revision)
  204. ICRP Publication 66‏‎ (1 revision)
  205. ICRP Publication 80‏‎ (1 revision)
  206. Somatic effect‏‎ (1 revision)
  207. Targeted effects‏‎ (1 revision)
  208. Active detection system‏‎ (1 revision)
  209. Typical value‏‎ (1 revision)
  210. ICRP Publication 100‏‎ (1 revision)
  211. Particle transport‏‎ (1 revision)
  212. ICRP Publication 112‏‎ (1 revision)
  213. ICRP Publication 127‏‎ (1 revision)
  214. ICRP Publication 141‏‎ (1 revision)
  215. ICRP Publication 17‏‎ (1 revision)
  216. Count median diameter‏‎ (1 revision)
  217. Radon-prone area‏‎ (1 revision)
  218. ICRP Publication 30 (Index)‏‎ (1 revision)
  219. Reference Person‏‎ (1 revision)
  220. ICRP Publication 38‏‎ (1 revision)
  221. Relative life lost‏‎ (1 revision)
  222. ICRP Publication 52‏‎ (1 revision)
  223. Dose commitment‏‎ (1 revision)
  224. ICRP Publication 99‏‎ (1 revision)
  225. ICRP Publication 67‏‎ (1 revision)
  226. Doubling dose‏‎ (1 revision)
  227. Security screening‏‎ (1 revision)
  228. ICRP Publication 81‏‎ (1 revision)
  229. Evacuation‏‎ (1 revision)
  230. Stochastic effect‏‎ (1 revision)
  231. Exposure index‏‎ (1 revision)
  232. AML/eto‏‎ (1 revision)
  233. Frequent flyer‏‎ (1 revision)
  234. Tolerance dose‏‎ (1 revision)
  235. Attributable risk‏‎ (1 revision)
  236. Occupancy factor‏‎ (1 revision)
  237. ICRP Publication 101‏‎ (1 revision)
  238. Best available techniques‏‎ (1 revision)
  239. ICRP Publication 113‏‎ (1 revision)
  240. Bronchiolar region‏‎ (1 revision)
  241. ICRP Publication 128‏‎ (1 revision)
  242. ICRP Publication 142‏‎ (1 revision)
  243. Compartment‏‎ (1 revision)
  244. ICRP Publication 18‏‎ (1 revision)
  245. Cross section‏‎ (1 revision)
  246. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  247. Deposition‏‎ (1 revision)
  248. ICRP Publication 39‏‎ (1 revision)
  249. Digital breast tomosynthesis‏‎ (1 revision)
  250. Relative risk‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:FewestRevisions"